Skip to content
Haase Lab: Hypoxia Responses in Physiology and Pathogenesis Logo Haase Lab: Hypoxia Responses in Physiology and Pathogenesis Logo
  • Home
  • Research
    • The Hypoxia-Inducible Factor Pathway – Overview
    • Oxygen-Regulation of Erythropoiesis and Iron Metabolism
    • Oxygen Sensing in Kidney Injury
    • Ischemic Pre-Conditioning of the Kidney
    • VHL Disease and Renal Cell Cancer
    • Research Protocols
  • Publications
    • Journal Articles
    • Book Chapters and Media Files
    • Archive
  • People
    • Haase Lab Team
    • Clinical Teams
  • Opportunities
  • Contact
  • Restricted
  • Home
  • Research
    • The Hypoxia-Inducible Factor Pathway – Overview
    • Oxygen-Regulation of Erythropoiesis and Iron Metabolism
    • Oxygen Sensing in Kidney Injury
    • Ischemic Pre-Conditioning of the Kidney
    • VHL Disease and Renal Cell Cancer
    • Research Protocols
  • Publications
    • Journal Articles
    • Book Chapters and Media Files
    • Archive
  • People
    • Haase Lab Team
    • Clinical Teams
  • Opportunities
  • Contact
  • Restricted
Haase et al., Nephrol Dial Transplant. 2018
Gallery
Haase et al., Nephrol Dial Transplant. 2018Volker Haase2018-09-08T14:47:35-05:00
HIF-prolyl hydroxylases in renal development
Kobayashi et al., Kidney Int. 2017
Gallery
Kobayashi et al., Kidney Int. 2017Volker Haase2018-10-04T22:57:39-05:00

NAVIGATION

News

  • Vadadustat in Hemodialysis Patients
  • PHD Oxygen Sensors in Kidney Development
  • Research News
  • International Meetings

Publications

  • Journal Articles
  • Book Chapters and Media Files
  • Archive

Haase Lab
Vanderbilt University

MCN C-3107
1161 21st Avenue So.
Nashville, TN 37232-2372
615.322.4157 (phone)
615.322.6854 (fax)

Privacy policy  Disclaimer

News

  • Vadadustat in hemodialysis
  • Haase lab research news
  • International meetings

click for more …

click to share …

Recent papers

Figure, AJKD commentary HIF-prolyl hydroxylases in renal development Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
© 2018 VOLKER H. HAASE - ALL RIGHTS RESERVED. advancing HIF biology and HIF-based therapies
We set cookies and use third-party services to enhance your experience on our website. If you continue to use this site and click on any links or scroll, we will assume that you are accepting our privacy policy and that you are consenting to the use of cookies including those from third parties.AcceptRefusePrivacy policy
Revoke cookies